Sánchez I, Xu C J, Juo P, Kakizaka A, Blenis J, Yuan J
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Neuron. 1999 Mar;22(3):623-33. doi: 10.1016/s0896-6273(00)80716-3.
We show here that caspase-8 is required for the death of primary rat neurons induced by an expanded polyglutamine repeat (Q79). Expression of Q79 recruited and activated caspase-8. Inhibition of caspase-8 blocked polyglutamine-induced cell death. Coexpression of Q79 with the caspase inhibitor CrmA, a dominant-negative mutant of FADD (FADD DN), Bcl-2, or Bcl-xL, but not an N-terminally tagged Bcl-xL, prevented the recruitment of caspase-8 and inhibited polyglutamine-induced cell death. Furthermore, Western blot analysis revealed the presence of activated caspase-8 in the insoluble fraction of affected brain regions from Huntington's disease (HD) patients but not in those from neurologically unremarkable controls, suggesting the relocation and activation of caspase-8 during the pathogenesis of HD. These results suggest an essential role of caspase-8 in HD-related neural degenerative diseases.
我们在此表明,胱天蛋白酶-8对于由扩展的聚谷氨酰胺重复序列(Q79)诱导的原代大鼠神经元死亡是必需的。Q79的表达募集并激活了胱天蛋白酶-8。抑制胱天蛋白酶-8可阻断聚谷氨酰胺诱导的细胞死亡。Q79与胱天蛋白酶抑制剂CrmA、FADD的显性负性突变体(FADD DN)、Bcl-2或Bcl-xL(但不是N端标记的Bcl-xL)共表达,可阻止胱天蛋白酶-8的募集并抑制聚谷氨酰胺诱导的细胞死亡。此外,蛋白质印迹分析显示,在亨廷顿舞蹈病(HD)患者受影响脑区的不溶性部分存在活化的胱天蛋白酶-8,而在神经功能正常的对照者中则不存在,这表明在HD发病机制中胱天蛋白酶-8发生了重新定位和激活。这些结果表明胱天蛋白酶-8在与HD相关的神经退行性疾病中起重要作用。